In Focus

  • WHO GISRS Bioinformatics Training Workshop with leading experts on the Eve of Options X

    Cape Town 2013

    GISRS Bioinformatics Training Workshop with leading experts held in Singapore

    The WHO Global Influenza Programme, together with the National Centre for Infectious Diseases and the Bioinformatics Institute Singapore and the GISAID Initiative are holding a 2-day influenza bioinformatics workshop with hands-on sessions provided by leading experts in their respective fields, preceding the Options for the Control of Influenza X on 26-27 August 2019.

    Participants will receive training on the GISAID EpiFlu™ database to monitor complex epidemiological relationships among circulating animal and human influenza viruses and the detection and interpretation of evolutionary change using FluSurver and Nextflu.

    > download training agenda

  • 23 May 2019 H7N9 Inner Monoglia, Eurosurveillance

    re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, in 2019

    Re-emergence of highly pathogenic avian influenza H7N9 viruses in humans in mainland China, in 2019

    A severe human case of highly pathogenic avian influenza (HPAI) H7N9 occurred in late March 2019 in the Inner Mongolia autonomous region of China. The case resided near a poultry slaughtering stall, prompting immediate environmental sampling of this location.

    Phylogenetic analyses of the virus showed that the sequences from the case and from several environmental samples formed a distinct clade from the gene sequences from viruses collected in 2017. Comparison with a candidate vaccine strain showed several mutations, possibly associated with antigenic drift which has yet to be characterized. No human cases of H7N9 were reported for over a year previously.

    Eurosurveillance, Volume 24, Issue 21, 23/May/2019

  • CBD Study finds GISAID might provide useful lessons and insight to ABS discussion

    CBD Study finds 'GISAID might provide useful lessons and insight to ABS discussions'

    A peer-reviewed fact-finding and scoping study on digital sequence information on genetic resources in the context of the Convention on Biological Diversity and the Nagoya Protocol, highlights key advantages of GISAID’s sharing mechanism and a fair and equitable benefit-sharing resulting from access to data.

    With the core principals of timely international sharing of health data for protecting populations against lethal infectious disease outbreaks and adherence to scientific etiquette of acknowledgement of the source of data has resulted in global trust and confidence in GISAID. 

    > download the fact-finding & scoping study

  • 21 March 2019 [VCM North 2019]

    Recommended composition of influenza virus vaccines for use in the 2019-2020 Northern Hemisphere Influenza Season announced

    On 21 February 2019 WHO announced a recommendation on the composition of three of the four components of influenza vaccines for use in the 2019-2020 northern hemisphere influenza season. The decision on the A(H3N2) component was postponed until 21 March 2019 to allow more time to better understand the distribution and proportions of recently circulating antigenically and genetically diverse A(H3N2) viruses and to develop and fully characterize appropriate candidate vaccine viruses.

    read more:

  • 19 May 2017 G20 Health Ministers

    G20 Health Ministers recognize the importance of GISAID in regard to virus data sharing

    At the invitation of Germany, the first meeting of Health Ministers of the Group of Twenty leading industrialized and emerging economies (G20) took place in Berlin between 19-20 May 2017.

    Under the banner of “Together Today for a Healthy Tomorrow – Joint Commitment for Shaping Global Health”, the two-day meeting focused on combating global health hazards. In their Berlin Declaration, the G20 Health Ministers recognize the importance of the Global Initiative on Sharing All Influenza Data (GISAID).

    > read more
    > The Berlin Declaration of the G20 Health Ministers (2017)

Public-Private Partnerships of the GISAID Initiative

The GISAID Initiative, also known as a Global Initiative on Sharing All Influenza Data, involves public-private-partnerships between the Initiative's administrative arm Freunde of GISAID e.V., a registered non-profit association, and governments of the Federal Republic of Germany, the official host of the GISAID platform and EpiFlu™ database, Singapore and the United States of America, with support from private and corporate philanthropy.